35 related articles for article (PubMed ID: 26780928)
1. Macroscopic inhibition of DNA damage repair pathways by targeting AP-2α with LEI110 eradicates hepatocellular carcinoma.
Wang C; Zhao Z; Zhao Y; Zhao J; Xia L; Xia Q
Commun Biol; 2024 Mar; 7(1):342. PubMed ID: 38503825
[TBL] [Abstract][Full Text] [Related]
2. Multidimensional quantitative phenotypic and molecular analysis reveals neomorphic behaviors of p53 missense mutants.
Pal A; Gonzalez-Malerva L; Eaton S; Xu C; Zhang Y; Grief D; Sakala L; Nwekwo L; Zeng J; Christensen G; Gupta C; Streitwieser E; Singharoy A; Park JG; LaBaer J
NPJ Breast Cancer; 2023 Sep; 9(1):78. PubMed ID: 37773066
[TBL] [Abstract][Full Text] [Related]
3. The comprehensive investigation of transcription factor AP-2 alpha in lung adenocarcinoma.
Liao H; Lin P
Transl Cancer Res; 2020 Mar; 9(3):1547-1557. PubMed ID: 35117502
[TBL] [Abstract][Full Text] [Related]
4. WWOX Loses the Ability to Regulate Oncogenic AP-2γ and Synergizes with Tumor Suppressor AP-2α in High-Grade Bladder Cancer.
Kołat D; Kałuzińska Ż; Bednarek AK; Płuciennik E
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34204827
[TBL] [Abstract][Full Text] [Related]
5. A positive feedback loop between Periostin and TGFβ1 induces and maintains the stemness of hepatocellular carcinoma cells via AP-2α activation.
Chen G; Wang Y; Zhao X; Xie XZ; Zhao JG; Deng T; Chen ZY; Chen HB; Tong YF; Yang Z; Ding XW; Guo PY; Yu HT; Wu LJ; Zhang SN; Zhu QD; Li JJ; Shan YF; Yu FX; Yu ZP; Xia JL
J Exp Clin Cancer Res; 2021 Jun; 40(1):218. PubMed ID: 34193219
[TBL] [Abstract][Full Text] [Related]
6. All-trans retinoic acid reverses malignant biological behavior of hepatocarcinoma cells by regulating miR-200 family members.
Cui J; Gong M; Fang S; Hu C; Wang Y; Zhang J; Tang N; He Y
Genes Dis; 2021 Jul; 8(4):509-520. PubMed ID: 34179313
[TBL] [Abstract][Full Text] [Related]
7. Lack of GD3 synthase (St8sia1) attenuates malignant properties of gliomas in genetically engineered mouse model.
Ohkawa Y; Zhang P; Momota H; Kato A; Hashimoto N; Ohmi Y; Bhuiyan RH; Farhana Y; Natsume A; Wakabayashi T; Furukawa K; Furukawa K
Cancer Sci; 2021 Sep; 112(9):3756-3768. PubMed ID: 34145699
[TBL] [Abstract][Full Text] [Related]
8. Fragile Gene
Kołat D; Kałuzińska Ż; Płuciennik E
Front Oncol; 2021; 11():621060. PubMed ID: 33718178
[TBL] [Abstract][Full Text] [Related]
9. TFAP2A Induced ITPKA Serves as an Oncogene and Interacts with DBN1 in Lung Adenocarcinoma.
Guoren Z; Zhaohui F; Wei Z; Mei W; Yuan W; Lin S; Xiaoyue X; Xiaomei Z; Bo S
Int J Biol Sci; 2020; 16(3):504-514. PubMed ID: 32015686
[TBL] [Abstract][Full Text] [Related]
10. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.
Huang W; Zhong Z; Luo C; Xiao Y; Li L; Zhang X; Yang L; Xiao K; Ning Y; Chen L; Liu Q; Hu X; Zhang J; Ding X; Xiang S
Theranostics; 2019; 9(19):5497-5516. PubMed ID: 31534499
[TBL] [Abstract][Full Text] [Related]
11. TFAP2A Induced KRT16 as an Oncogene in Lung Adenocarcinoma via EMT.
Yuanhua L; Pudong Q; Wei Z; Yuan W; Delin L; Yan Z; Geyu L; Bo S
Int J Biol Sci; 2019; 15(7):1419-1428. PubMed ID: 31337972
[No Abstract] [Full Text] [Related]
12. The biological characteristics of transcription factors AP-2α and AP-2γ and their importance in various types of cancers.
Kołat D; Kałuzińska Ż; Bednarek AK; Płuciennik E
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30824562
[TBL] [Abstract][Full Text] [Related]
13. AP-2α expression in papillary thyroid carcinoma predicts tumor progression and poor prognosis.
Wu HR; Zhang J
Cancer Manag Res; 2018; 10():2615-2625. PubMed ID: 30147362
[TBL] [Abstract][Full Text] [Related]
14. The SHH/Gli axis regulates CD90-mediated liver cancer stem cell function by activating the IL6/JAK2 pathway.
Zhang K; Che S; Pan C; Su Z; Zheng S; Yang S; Zhang H; Li W; Wang W; Liu J
J Cell Mol Med; 2018 Jul; 22(7):3679-3690. PubMed ID: 29722127
[TBL] [Abstract][Full Text] [Related]
15. Serine hydroxymethyl transferase 1 stimulates pro-oncogenic cytokine expression through sialic acid to promote ovarian cancer tumor growth and progression.
Gupta R; Yang Q; Dogra SK; Wajapeyee N
Oncogene; 2017 Jul; 36(28):4014-4024. PubMed ID: 28288142
[TBL] [Abstract][Full Text] [Related]
16. AP-2α inhibits hepatocellular carcinoma cell growth and migration.
Huang W; Chen C; Liang Z; Qiu J; Li X; Hu X; Xiang S; Ding X; Zhang J
Int J Oncol; 2016 Mar; 48(3):1125-34. PubMed ID: 26780928
[TBL] [Abstract][Full Text] [Related]
17. AP-2β inhibits hepatocellular carcinoma invasion and metastasis through Slug and Snail to suppress epithelial-mesenchymal transition.
Yang L; Qiu J; Xiao Y; Hu X; Liu Q; Chen L; Huang W; Li X; Li L; Zhang J; Ding X; Xiang S
Theranostics; 2018; 8(13):3707-3721. PubMed ID: 30026878
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
